Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for depressive symptoms in women with polycystic ovary syndrome
IRCT20251112067975N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Metformin with Placebo (2 arms). Primary endpoints: Depression symptom score by Hamilton Depression Inventory, Fasting blood sugar and 6 more. Started Dec 2025; status: completed.
02
Drugs
metformin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20251112067975N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251112067975N1.